Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 129 of 1,261
  1. US 11932867

    Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene

    The Regents of the University of Colorado, a Body Corporate Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  2. US 11932852

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Benitec IP Holdings Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  3. US 11932726

    Method of making releasable polymeric reagents

    Nektar Therapeutics Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  4. US 11932856

    RNA targeting of mutations via suppressor tRNAs and deaminases

    The Regents of the University of California Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  5. US 11932851

    Exon skipping compositions for treating muscular dystrophy

    Sarepta Therapeutics, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  6. US 11932635

    CRBN ligands and uses thereof

    Kymera Therapeutics, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  7. US 11932695

    Modified antibodies and related compounds, compositions and methods of use

    Sensei Biotherapeutics, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  8. US 11932653

    Lycorine derivative, and pharmaceutical composition and use thereof

    BEIJING DYNE HIGH-TECH PEDIATRIC PHARMACEUTICAL R&D INSTITUTE CO., LTD. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  9. US 11932688

    Treatment for neoplastic diseases

    XBIOTECH INC. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  10. US 11931481

    Microporous annealed particle gel system

    The Regents of the University of California Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  11. US 11932617

    Compound for use in retinal diseases

    ZHUHAI UNITED LABORATORIES CO., LTD. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  12. US 11932692

    Methods of treating cancer pain by administering a PD-1 inhibitor

    REGENERON PHARMACEUTICALS, INC. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  13. US 11931402

    Compositions for treating heart disease by inhibiting the action of mAKAP-Ξ²

    Anchored RSK3 Inhibitors, LLC Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  14. US 11932624

    MDM2 degraders and uses thereof

    Kymera Therapeutics, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  15. US 11932600

    Biaryl derivative

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  16. US 11932871

    Methods of culturing t cells and uses of same

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  17. US 11932606

    Anti-cancer/anti-fibrosis compounds

    The Regents of the University of California Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  18. US 11933781

    Fibrosis model and methods of use thereof

    The Regents of the University of Colorado Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  19. US 11931336

    Enhancing autophagy or increasing longevity by administration of urolithins

    Amazentis SA Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  20. US 11932705

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  21. US 11931480

    Microporous annealed particle gels and methods of use

    The Regents of the University of California Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  22. US 11931335

    Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

    Amazentis SA Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  23. US 11931354

    Formulations of oxabicycloheptanes and oxabicycloheptenes

    Lixte Biotechnology, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  24. US 11931328

    Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

    AMNEAL PHARMACEUTICALS LLC Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.